Heidi A Phillips

age ~62

from Cypress, TX

Get Report

Also known as:

Heidi Allen Phillips
Heidi Jean Roush
Heidi J Roush
Heidi A Roush
Heidi J Allen
Heldi Roush
Heidl Roush
Roush Heidl

Connected to:

Heidi Phillips Phones & Addresses

Cypress, TX
Argyle, TX
Richardson, TX
Dallas, TX
Fort Worth, TX
Grapevine, TX
Colleyville, TX
Pampa, TX
Norwalk, CT
3716 W 5Th St, Fort Worth, TX 76107

License Records

Heidi Sue Phillips

License #:

18684 - Expired

Category:

Nursing

Issued Date:

Oct 18, 2002

Effective Date:

Dec 5, 2005

Expiration Date:

Oct 31, 2005

Type:

Licensed Practical Nurse

Heidi Sue Phillips

License #:

48615 - Expired

Category:

Nursing Support

Issued Date:

Sep 26, 2000

Effective Date:

Aug 21, 2004

Type:

Nurse Aide

Name / Title

Company / Classification

Phones & Addresses

Heidi Phillips
Director, Secretary

Oak Harbour, Section Four, Condominium Association, Inc
Civic and Social Associations

Us Patents

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20080124344, May 29, 2008
Filed:

Jul 18, 2006
Appl. No.:

11/814549
Inventors:

Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Juan Delmas-Mata - Spring TX, US
Frederic de Sauvage - Foster City CA, US
Liangfen Fan - Spring TX, US
Gretchen Frantz - San Francisco CA, US
Leslie Jane Green - Conroe TX, US
Erin Marie Massey - Conroe TX, US
Dina Rebecca McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Bobby Joe Payne - The Woodlands TX, US
Franklin Peale - San Carlos CA, US
Heidi Phillips - Palo Alto CA, US
Michelle Rohrer - San Carlos CA, US
Tracy E.W. Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - Dallas TX, US
Tracy Tzu-Ling Tang - Redwood City CA, US
Ching-Yun Wang - The Woodlands TX, US
Wen Xiong - Tomball TX, US
Peter Vogel - The Woodlands TX, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
A01K 67/00
A61P 43/00
US Classification:

4241721, 800 3, 800 13, 800 9
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20080311107, Dec 18, 2008
Filed:

Feb 9, 2007
Appl. No.:

11/814136
Inventors:

Kristi Rae Bollinger - Tomball TX, US
Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Frederic J. de Sauvage - Foster City CA, US
Joel A. Edwards - The Woodlands TX, US
Leslie Jane Green - Conroe TX, US
Rosemary Girgis - Houston TX, US
Allison Anne Byers Horner - Dickinson TX, US
Dina Rebecca McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Laurie Jeanette Minze - Katy TX, US
Bobby Joe Payne - The Woodlands TX, US
Heidi Phillips - Palo Alto CA, US
Trac Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - The Woodlands TX, US
Tracy Tzu-Ling Tang - Redwood City CA, US
Teresa Gail Townsend - Houston TX, US
Peter Vogel - The Woodlands TX, US
Assignee:

Genetech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
A61K 51/00
C12N 5/06
A61P 25/00
A61P 27/12
C07K 16/00
US Classification:

4241301, 800 3, 435352, 5303871
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO188, PRO235, PRO266, PRO337, PRO361, PRO539, PRO698, PRO717, PRO846, PRO874, PRO98346, PRO1082, PRO1097, PRO1192, PRO1268, PRO1278, PRO1303, PRO1308, PRO1338, PRO1378, PRO1415, PRO1867, PRO1890, PRO3438, PRO19835, PRO36915, PRO36029, PRO4999, PRO5778, PRO5997, PRO6079, PRO6090, PRO7178, PRO21184, PRO7434, PRO9822, PRO9833, PRO9836, PRO9854, PRO9862, PRO10284, PRO37510, PRO35444, PRO20473, PRO21054 or PRO35246 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20090313707, Dec 17, 2009
Filed:

May 18, 2006
Appl. No.:

11/814361
Inventors:

Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Frederic J. de Sauvage - Foster City CA, US
Zhiyong Ding - Longmont CO, US
Joel Edwards - The Woodlands TX, US
Rosemary Girgis - Houston TX, US
Allison A. B. Horner - Dickinson TX, US
Harald Junge - Burlingame CA, US
Jagath Reddy Junutula - Fremont CA, US
Erin Marie Massey - Conroe TX, US
Dina R. McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Bobby Joe Payne - The Woodlands TX, US
Heidi Phillips - Palo Alto CA, US
Ni Nancy Qian - San Diego CA, US
Carolina Rangel - Houston TX, US
Tracy E. W. Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - Dallas TX, US
Peter Vogel - The Woodlands TX, US
Weilan Ye - Foster City CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
Lexicon Pharamaceuticals, Inc. - The Woodlands TX
International Classification:

G01N 33/00
C12N 5/06
C12Q 1/02
US Classification:

800 3, 435325, 435354, 435 29
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20110173708, Jul 14, 2011
Filed:

Feb 18, 2011
Appl. No.:

13/031009
Inventors:

Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Juan Delmas-Mata - Spring TX, US
Frederic de Sauvage - Foster City CA, US
Liangfen Fan - Spring TX, US
Gretchen Frantz - San Francisco CA, US
Leslie Jane Green - Conroe TX, US
Erin Marie Massey - Conroe TX, US
Dina Rebecca McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Bobby Joe Payne - The Woodlands TX, US
Franklin Peale - San Carlos CA, US
Heidi Phillips - Palo Alto CA, US
Michelle Rohrer - San Carlos CA, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - Dallas TX, US
Tracy Tzu-Ling Tang - Redwood City CA, US
Ching-Yun Wang - The Woodlands TX, US
Wen Xiong - Tomball TX, US
Peter Vogel - The Woodlands TX, US
International Classification:

G01N 33/00
US Classification:

800 3
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20110182883, Jul 28, 2011
Filed:

Mar 3, 2011
Appl. No.:

13/040049
Inventors:

Katherin E. Combs - Spring TX, US
Frederic de Sauvage - Foster City CA, US
Liangfen Fan - Spring TX, US
Ellen Filvaroff - San Francisco CA, US
Allison Anne Byers Horner - Dickinson TX, US
Bryan Irving - San Francisco CA, US
Jagath Reddy Junutula - Fremont CA, US
Erin Marie Massey - Conroe TX, US
Dina Rebecca Mclain - San Antonio TX, US
Laurie Jeanette Minze - Katy TX, US
Charles Montgomery - Jay OK, US
Bobby Joe Payne - The Woodlands TX, US
Heidi Phillips - Palo Alto CA, US
Carolina Rangel - Houston TX, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - Dallas TX, US
Teresa Gail Townsend - Houston TX, US
Peter Vogel - The Woodlands TX, US
International Classification:

A61K 39/395
A61P 3/00
A61P 9/00
A61P 25/00
A61P 19/00
G01N 33/00
US Classification:

4241301, 800 3
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO218, PRO228, PRO271, PRO273, PRO295, PRO302, PRO305, PRO326, PRO386, PRO655, PRO162, PRO788, PRO792, PRO940, PRO941, PRO1004, PRO1012, PRO1016, PRO474, PRO5238, PRO1069, PRO1111, PRO1113, PRO1130, PRO1195, PRO1271, PRO1865, PRO1879, PRO3446, PRO3543, PRO4329, PRO4352, PRO5733, PRO9859, PRO9864, PRO9904, PRO9907, PRO10013, PRO90948, PRO28694, PRO16089, PRO19563, PRO19675, PRO20084, PRO21434, PRO50332, PRO38465 or PRO346 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Methods Of Identifying Agents That Modulate Phenotypes Related To Disruptions, Of A Gene Encoding Pro235 Polypeptide
view source
US Patent:

20120005766, Jan 5, 2012
Filed:

Aug 9, 2011
Appl. No.:

13/205917
Inventors:

Kristi Rae Bollinger - Tomball TX, US
Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Frederic J. de Sauvage - Foster City CA, US
Joel Edwards - The Woodlands TX, US
Leslie Jane Green - Conroe TX, US
Rosemary Girgis - Houston TX, US
Allison Anne Byers Horner - Dickinson TX, US
Dina Rebecca McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Laurie Jeanette Minze - Katy TX, US
Bobby Joe Payne - The Woodlands TX, US
Heidi Phillips - Palo Alto CA, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - The Woodlands TX, US
Tracy Tzu-Ling Tang - Redwood City CA, US
Teresa Gail Townsend - Houston TX, US
Peter Vogel - The Woodlands TX, US
International Classification:

A61K 49/00
C12Q 1/68
C40B 30/04
C12Q 1/02
US Classification:

800 3, 435 29, 435 612, 506 9
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO188, PRO235, PRO266, PRO337, PRO361, PRO539, PRO698, PRO717, PRO846, PRO874, PRO98346, PRO1082, PRO1097, PRO1192, PRO1268, PRO1278, PRO1303, PRO1308, PRO1338, PRO1378, PRO1415, PRO1867, PRO1890, PRO3438, PRO19835, PRO36915, PRO36029, PRO4999, PRO5778, PRO5997, PRO6079, PRO6090, PRO7178, PRO21184, PRO7434, PRO9822, PRO9833, PRO9836, PRO9854, PRO9862, PRO10284, PRO37510, PRO35444, PRO20473, PRO21054 or PRO35246 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; cyc abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20120030776, Feb 2, 2012
Filed:

Oct 22, 2010
Appl. No.:

12/910746
Inventors:

Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Frederic de Sauvage - Foster City CA, US
Zhiyong Ding - Longmont CO, US
Joel Edwards - The Woodlands TX, US
Rosemary Girgis - Houston TX, US
Allison Anne Byers Horner - Dickinson TX, US
Harald Junge - Burlingame CA, US
Jagath Reddy Junutula - Fremont CA, US
Erin Marie Massey - Conroe TX, US
Dina Rebecca McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Bobby Joe Payne - The Woodlands TX, US
Heidi Phillips - Palo Alto CA, US
Ni Nancy Qian - San Diego CA, US
Carolina Rangel - Houston TX, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - Dallas TX, US
Peter Vogel - The Woodlands TX, US
Weilan Ye - Foster City CA, US
International Classification:

A61K 49/00
C12Q 1/48
C12Q 1/42
C40B 30/04
C12Q 1/02
US Classification:

800 3, 506 9, 435 29, 435 21, 435 15
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Novel Gene Disruptions, Compositions And Methods Relating Thereto
view source
US Patent:

20120272341, Oct 25, 2012
Filed:

May 16, 2012
Appl. No.:

13/473322
Inventors:

Katherin E. Combs - Spring TX, US
Ling Ling Culbertson - Spring TX, US
Juan Delmas-Mata - Spring TX, US
Frederic de Sauvage - Foster City CA, US
Liangfen Fan - Spring TX, US
Gretchen Frantz - San Francisco CA, US
Leslie Jane Green - Conroe TX, US
Erin Marie Massey - Conroe TX, US
Dina Rebecca McLain - San Antonio TX, US
Charles Montgomery - Jay OK, US
Bobby Joe Payne - The Woodlands TX, US
Franklin Peale - San Carlos CA, US
Heidi Phillips - Palo Alto CA, US
Michelle Rohrer - San Carlos CA, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - Dallas TX, US
Tracy Tzu-Ling Tang - Redwood City CA, US
Ching-Yun Wang - The Woodlands TX, US
Wen Xiong - Tomball TX, US
Peter Vogel - The Woodlands TX, US
International Classification:

G01N 33/50
C12Q 1/02
G01N 33/92
G01N 33/483
US Classification:

800 3, 435 29
Abstract:

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Resumes

Loan Processor At Home Usa Mortgage

view source

Position:

Loan Processor at Home USA Mortgage

Location:

United States

Industry:

Executive Office

Work:

Home USA Mortgage since Jan 2010
Loan Processor
Little Giant Solutions Dec 2008 - Jan 2010
Innovations Director
Wing Enterprises Dec 2008 - Jan 2010
Innovations Director
Amicus Homes LLC May 2006 - Jan 2008
Office Manager

Education:

Brigham Young University 2003 - 2007
BS, Health and Human Performance